Bacteremias at a teaching hospital: Etiology, antimicrobial susceptibiliy pattern and risk factors for mortality;Bacteremias em pacientes internados em hospital universitário

Revista da Associacao Medica Brasileira

Volumn 53, Issue 1, 2007, Pages 34-38

  Guilarde, Adriana Oliveira ^a,b   Turchi, Marília Dalva ^a   Martelli, Celina Maria Turchi ^a   Primo, Mariusa Gomes Borges ^a   Batista, Lindon Johnson De Abreu ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b NONE   (Brazil)

Author keywords

Bacteremia; Nosocomial infection; Staphylococcus aureus; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BRAZIL; CHILD; CROSS INFECTION; EPIDEMIOLOGY; FEMALE; HUMAN; INFANT; LENGTH OF STAY; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PENICILLIN RESISTANCE; PRESCHOOL CHILD; PROGNOSIS; STATISTICS; TEACHING HOSPITAL; TIME; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; BACTEREMIA; BRAZIL; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; EPIDEMIOLOGIC METHODS; FEMALE; HOSPITALS, TEACHING; HUMANS; INFANT; LENGTH OF STAY; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PROGNOSIS; TIME FACTORS; TREATMENT FAILURE;

EID: 34247155373     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302007000100016     Document Type: Article

References (38)

1. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29:S109-S16.
2. Baine WB, Yu W, Summe JP. The epidemiology of hospitalization of elderly americans for or bacteremia in 1991-1998: Application of Medicare Claims Data. Ann Epidemiol. 2001;11:118-26.
3. Bone R, Balk RA, Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644-55.
4. Bustamante-Teixeira MT, Faerstein E, Latorre MR. Técnicas de análise de sobrevida. Cad Saúde Pública. 2002;18:579-94.
5. Camargo LF, Strabelli TM, Ribeiro F, Mendes CM, Uip D, Belloti G, Pileggi F. Bacteremias hospitalares no Instituto do Coração do Hospital das Clínicas da FMUSP: estudo retrospectivo de quatro anos consecutivos. Rev Hosp CLin Fac Med São Paulo. 1994;49:168-72.
6. Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 1998;19:32-7.
7. Cookson B. Controversies: is it time to stop searching for MRSA? BMJ. 1997;314: 664.
8. Correa L, Pittet D. Problems and solutions in hospital-adquired bacteraemia. J Hosp Infect. 2000;46:89-95.
9. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999;29:239-44.
10. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY Antimicrobial Surveillance Program, 1997-1998. Clin Infect Dis. 2000;30:454-60.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections,1988. Am J Infect Control. 1988;16:128-40.
12. Geerdes HF, Ziegler D, Lode H, Hund M, Loehr A, Fangmann W, Wagner J. Bacteremia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis. 1992;15:991-1002.
13. Harbarth S, Ferrière K, Hugonnet S, Ricou B, Suter P, Pittet D. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg. 2002;137:1353-9.
14. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146-55.
15. Karchmer AW. Nosocomial bloodstream infections: organisms, factors, and implications. Clin Infect Dis. 2000;31:S139-43.
16. Kleinbaum D. The Cox proportional hazards model and its characteristics. In: Kleinbaum D. Survival analysis: self-learning text. New York: Sprinjer-Verlag; 1996. p.83-128.
17. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000;31:S131-S8.
18. Lark RL, Chenoweth C, Saint S, Zemencuk JK, Lipsky BA, Plorde JJ. Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis. 2000;38:131-40.
19. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-54.
20. Moreira M, Medeiros EAS, Pignatari ACC, Wey SB, Cardo DM. Efeito da infecção hospitalar da corrente sangüínea por Staphylococcus aureus resistente à oxacilina sobre a letalidade e o tempo de hospitalização. Rev Assoc Med Bras. 1998;44:263-8.
21. National Committee for Clinical Laboratory Standards. NCCLS. Methods for diluition antimicrobial suscetibility tests for bacteria that grow aerobically. 5th ed. NCCLS:20(2):document 2000;M7-A5.
22. Orsi GB, Stefano LD, Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol. 2002;23:190-7.
23. Pearson ML. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: An overview. Am J Infect Control. 1996;24:262-77.
24. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis. 1997;24:1068-78.
25. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598-601.
26. Pittet D, Wenzel RP. Nosocomial bloodstream infections. secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med. 1995;155:1177-84.
27. Reacher MH, Shah S, Livermore DM, Wale MCI, Graham C, Johnson A, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ. 2000;320:213-16.
28. Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteremia due to methicilin-resistant Staphylococcus aureus. Clin Infect Dis. 1995;21:1417-23.
29. Rupp ME, Archer GL. Coagulase-Negative Staphylococci: pathogens associated with medical progress. Clin Infect Dis. 1994;19:231-45.
30. Sader HS, Jones RN, Baiocchi SA, Biedenbach DJ. Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn Microbiol Infect Dis. 2002;44:273-80.
31. Salomão R, Castelo Filho A, Pignatari AC, Wey SB. Nosocomial and community acquired bacteremia: variables associated with outcomes. Rev Paul Med. 1993;111:456-61.
32. Silbert S, Matte U, Barcellos SH, Goldim JR. Hemoculturas no Hospital de Clínicas de Porto Alegre: uma análise de seis meses. Revista HCPA Fac Med Univ Fed Rio Gd Sul. 1996;16:28-30.
33. Thylefors JD, Harbarth S, Pittet D. Increasing bacteremia due to coagulase-negative Staphylococci: fiction or reality? Infect Control Hosp Epidemiol. 1998;19:581-89.
34. Tresoldi AT, Branchini MLM, Moreira Filho DC, Padoveze M, Dantas SPE, Reginato L, Nowakonski A, Oliveira UM, Trabasso P. Relative frequency of nosocomial microorganisms at Unicamp University Hospital from 1987 to 1994. Rev Inst Med Trop São Paulo 1997;39:333-36.
35. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24;584-602.
36. Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis. 2001;7:174-77.
37. Wenzel RP, Nettleman M, Jones RN, Pfaller MA. Methicilin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med. 1991;91:221-27.
38. Wisplinghoff H, Seifert H, Coimbra M, Wenzel RP, Edmond MB. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Staphylococcus aureus. Clin Infect Dis. 2001;33:733-6.